182 related articles for article (PubMed ID: 8537681)
1. Effective immunization with live attenuated influenza A virus can be achieved in early infancy. Pediatric Care Center.
Clements ML; Makhene MK; Karron RA; Murphy BR; Steinhoff MC; Subbarao K; Wilson MH; Wright PF
J Infect Dis; 1996 Jan; 173(1):44-51. PubMed ID: 8537681
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza Vaccine Investigators Group.
Gruber WC; Belshe RB; King JC; Treanor JJ; Piedra PA; Wright PF; Reed GW; Anderson E; Newman F
J Infect Dis; 1996 Jun; 173(6):1313-9. PubMed ID: 8648202
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of a cold-adapted influenza A (H1N1) reassortant virus vaccine administered to infants less than six months of age.
Karron RA; Steinhoff MC; Subbarao EK; Wilson MH; Macleod K; Clements ML; Fries LF; Murphy BR
Pediatr Infect Dis J; 1995 Jan; 14(1):10-6. PubMed ID: 7715982
[TBL] [Abstract][Full Text] [Related]
4. Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children.
King JC; Fast PE; Zangwill KM; Weinberg GA; Wolff M; Yan L; Newman F; Belshe RB; Kovacs A; Deville JG; Jelonek M;
Pediatr Infect Dis J; 2001 Dec; 20(12):1124-31. PubMed ID: 11740317
[TBL] [Abstract][Full Text] [Related]
5. A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.
Talaat KR; Karron RA; Callahan KA; Luke CJ; DiLorenzo SC; Chen GL; Lamirande EW; Jin H; Coelingh KL; Murphy BR; Kemble G; Subbarao K
Vaccine; 2009 Jun; 27(28):3744-53. PubMed ID: 19464558
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants.
Clements-Mann ML; Dudas R; Hoshino Y; Nehring P; Sperber E; Wagner M; Stephens I; Karron R; Deforest A; Kapikian AZ
Vaccine; 2001 Sep; 19(32):4676-84. PubMed ID: 11535316
[TBL] [Abstract][Full Text] [Related]
7. Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults.
Sears SD; Clements ML; Betts RF; Maassab HF; Murphy BR; Snyder MH
J Infect Dis; 1988 Dec; 158(6):1209-19. PubMed ID: 3198936
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease.
Edwards KM; Dupont WD; Westrich MK; Plummer WD; Palmer PS; Wright PF
J Infect Dis; 1994 Jan; 169(1):68-76. PubMed ID: 8277200
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the infectivity, immunogenicity, and efficacy of live cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in adult volunteers.
Clements ML; Snyder MH; Sears SD; Maassab HF; Murphy BR
J Infect Dis; 1990 May; 161(5):869-77. PubMed ID: 2324538
[TBL] [Abstract][Full Text] [Related]
10. Comparison of live attenuated cold-adapted and avian-human influenza A/Bethesda/85 (H3N2) reassortant virus vaccines in infants and children.
Steinhoff MC; Halsey NA; Wilson MH; Burns BA; Samorodin RK; Fries LF; Murphy BR; Clements ML
J Infect Dis; 1990 Aug; 162(2):394-401. PubMed ID: 2197335
[TBL] [Abstract][Full Text] [Related]
11. Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine.
Belshe RB; Swierkosz EM; Anderson EL; Newman FK; Nugent SL; Maassab HF
J Infect Dis; 1992 Apr; 165(4):727-32. PubMed ID: 1552202
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of live attenuated cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in infants and children.
Edwards KM; King JC; Steinhoff MC; Thompson J; Clements ML; Wright PF; Murphy BR
J Infect Dis; 1991 Apr; 163(4):740-5. PubMed ID: 2010627
[TBL] [Abstract][Full Text] [Related]
13. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity.
Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
J Hyg (Lond); 1983 Jun; 90(3):361-70. PubMed ID: 6863910
[TBL] [Abstract][Full Text] [Related]
14. Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults.
Keitel WA; Couch RB; Quarles JM; Cate TR; Baxter B; Maassab HF
J Infect Dis; 1993 Feb; 167(2):305-11. PubMed ID: 8421165
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilities.
Nolan T; Lee MS; Cordova JM; Cho I; Walker RE; August MJ; Larson S; Coelingh KL; Mendelman PM
Vaccine; 2003 Mar; 21(11-12):1224-31. PubMed ID: 12559802
[TBL] [Abstract][Full Text] [Related]
16. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine.
Johnson PR; Feldman S; Thompson JM; Mahoney JD; Wright PF
J Infect Dis; 1986 Jul; 154(1):121-7. PubMed ID: 3711685
[TBL] [Abstract][Full Text] [Related]
17. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
[TBL] [Abstract][Full Text] [Related]
18. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T
Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173
[TBL] [Abstract][Full Text] [Related]
19. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909
[TBL] [Abstract][Full Text] [Related]
20. Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.
Isakova-Sivak I; Rudenko L
Expert Rev Vaccines; 2015; 14(10):1313-29. PubMed ID: 26289975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
